The author, from Reimagine Care, discusses how AI can enhance oncology care by prioritizing patient needs, fostering trust, and streamlining communication through familiar text-based support for all ages.
November 2025
AI is poised to transform oncology with innovative tools enhancing diagnosis, treatment, and clinical trials, despite some wariness from clinicians and patients.
A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment landscape for relapsed/refractory multiple myeloma, focusing on the challenges of bringing bispecific antibodies to patients in an outpatient setting.
A white paper explores how biomarker testing enhances patient outcomes and what barriers prevent access several common cancers.
Experts discuss the urgent need for equitable access to cancer care, addressing barriers in treatment delivery and the importance of personalized medicine.
Experts discuss the intersection of innovation, affordability, and access in cancer care, focusing on multiple myeloma and NSCLC advancements.
Experts discuss the evolving landscape of CLL treatment, cellular therapies, and innovative diagnostics shaping patient care and cost-effectiveness in oncology.
Experts discuss the evolution of cancer care, emphasizing value-based approaches, precision oncology, and the importance of multidisciplinary collaboration for improved patient outcomes.
Advertisement
Advertisement
Trending on AJMC
1
FDA to Remove Black Box Warnings From HRT, Debate Ensues
2
Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen
3
Total Neoadjuvant Therapy May Aid Organ Preservation in Early Rectal Cancer
4
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart Failure
5
